Clinical, neuroelectrophysiological and muscular pathological analysis of chronic progressive external ophthalmoplegia

Lv,Haidong; Qu,Qianqian; Liu,Haiyan; Qian,Qi; Zheng,Xianzhao; Zhang,Yan

doi:10.3892/etm.2020.8822

Clinical, neuroelectrophysiological and muscular pathological analysis of chronic progressive external ophthalmoplegia

Authors:
- Haidong Lv
- Qianqian Qu
- Haiyan Liu
- Qi Qian
- Xianzhao Zheng
- Yan Zhang
View Affiliations

Affiliations: Department of Neurology, The People's Hospital of Jiaozuo City, Jiaozuo, Henan 454002, P.R. China
Published online on: May 30, 2020 https://doi.org/10.3892/etm.2020.8822
Pages: 1770-1774

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the clinical, neuroelectrophysiological and muscular pathological characteristics of chronic progressive external ophthalmoplegia (CPEO) and to improve the understanding of CPEO. Clinical manifestations, neuroelectrophysiology and pathological features of muscle biopsies from 12 patients with CPEO were retrospectively analyzed. The average age of onset for the 12 patients (6 males and 6 females) was 17.2 years. All patients had different degrees of blepharoptosis. A total of 11 patients experienced ocular dyskinesia, but diplopia was rare. Electrophysiological testing in 12 patients revealed abnormal changes in 6 patients, including 4 patients with a myogenic lesion, 1 patient with a neurogenic lesion, and 1 patient with mixed myogenic/neurogenic lesions. Two patients had slow sensory nerve conduction velocity. Muscle biopsies in 12 patients demonstrated ragged‑red, irregular and broken fibers in 11 patients through Gomori trichrome and hematoxylin and eosin (H&E) staining, increased lipid levels in some muscle fibers in 4 patients through Οil Ρed O staining and abnormal distribution of type I and II muscle fibers in 3 patients through ATPase staining. Electron microscopy in 5 patients showed an increased number of mitochondria and abnormal mitochondrial aggregation between submucosa and myofibrils in 4 patients. These findings suggest that the possibility of CPEO should be considered if patients present with obvious extraocular muscle paralysis without diplopia. Furthermore, the identification of ragged‑red fibers by Gomori trichrome and H&E staining of muscle biopsies from patients is an important basis for the diagnosis of CPEO.

View Figures

View References

1	López-Gallardo E, López-Pérez MJ, Montoya J and Ruiz-Pesini E: CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion. 9:314–317. 2009.PubMed/NCBI View Article : Google Scholar
2	Negro R, Zoccolella S, Dell’aglio R, Amati A, Artuso L, Bisceglia L, Lavolpe V, Papa S, Serlenga L and Petruzzella V: Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia. Neuromuscul Disord. 19:423–426. 2009.PubMed/NCBI View Article : Google Scholar
3	Murdock J, Thyparampil PJ and Yen MT: Late-onset development of eyelid ptosis in chronic progressive external ophthalmoplegia: A 30-year follow-up. Neuroophthalmology. 40:44–46. 2016.PubMed/NCBI View Article : Google Scholar
4	Filosto M, Mancuso M, Nishigaki Y, Pancrudo J, Harati Y, Gooch C, Mankodi A, Bayne L, Bonilla E, Shanske S, et al: Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase γ. Arch Neurol. 60:1279–1284. 2003.PubMed/NCBI View Article : Google Scholar
5	Brandon BR, Diederich NJ, Soni M, Witte K, Weinhold M, Krause M and Jackson S: Autosomal dominant mutations in POLG and C10orf2: Association with late onset chronic progressive external ophthalmoplegia and Parkinsonism in two patients. J Neurol. 260:1931–1933. 2013.PubMed/NCBI View Article : Google Scholar
6	Walker UA, Collins S and Byrne E: Respiratory chain encephalomyopathies: A diagnostic classification. Eur Neurol. 36:260–267. 1996.PubMed/NCBI View Article : Google Scholar
7	Chaturvedi S, Bala K, Thakur R and Suri V: Mitochondrial encephalomyopathies: Advances in understanding. Med Sci Monit. 11:RA238–RA246. 2005.PubMed/NCBI
8	Biousse V and Newman NJ: Neuro-ophthalmology of mitochondrial diseases. Curr Opin Neurol. 16:35–43. 2003.PubMed/NCBI View Article : Google Scholar
9	Bing Q, Hu J, Li N, Zhao Z, Shen HR and Yuan HH: Clinical and pathological features of chronic progressive external ophthalmoplegia. Linchuang Shenjingbingxue Zazhi. 22:175–177. 2009.(In Chinese).
10	Sun L, Lu JH and Lu ZZ: Clinical manifestations, pathological changes and diagnosis of chronic progressive external ophthalmoplegia (twelve cases attached). Fudan Daxue Yixueban. 36:212–215. 2009.(In Chinese).
11	Wallace DK, Sprunger DT, Helveston EM and Ellis FD: Surgical management of strabismus associated with chronic progressive external ophthalmoplegia. Ophthalmology. 104:695–700. 1997.PubMed/NCBI View Article : Google Scholar
12	Wu JL, Yan CZ, Wang QZ, Liu SP, Gao SQ, Zhang YQ and Li DN: Chronic progressive external ophthalmophegia: Clinical and pathological analysis of 22 cases. Zhonghua Shenjinke Zazhi. 38:737–740. 2005.(In Chinese).
13	Fournier E and Tabti N: Clinical electrophysiology of muscle diseases and episodic muscle disorders. Handb Clin Neurol. 161:269–280. 2019.PubMed/NCBI View Article : Google Scholar
14	Engel WK and Cunningham GG: Rapid examination of muscle tissue. An improved trichrome method for fresh-frozen biopsy sections. Neurology. 13:919–923. 1963.PubMed/NCBI View Article : Google Scholar
15	Shapira Y, Harel S and Russell A: Mitochondrial encephalomyopathies: A group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci. 13:161–164. 1977.PubMed/NCBI
16	Yamamoto M and Nonaka I: Skeletal muscle pathology in chronic progressive external ophthalmoplegia with ragged-red fibers. Acta Neuropathol. 76:558–563. 1988.PubMed/NCBI View Article : Google Scholar
17	Lee SJ, Na JH, Han J and Lee YM: Ophthalmoplegia in mitochondrial disease. Yonsei Med J. 59:1190–1196. 2018.PubMed/NCBI View Article : Google Scholar
18	Sachdev A, Fratter C and McMullan TF: Novel mutation in the RNASEH1 gene in a chronic progressive external ophthalmoplegia patient. Can J Ophthalmol. 53:e203–e205. 2018.PubMed/NCBI View Article : Google Scholar
19	Viscomi C and Zeviani M: MtDNA-maintenance defects: Syndromes and genes. J Inherit Metab Dis. 40:587–599. 2017.PubMed/NCBI View Article : Google Scholar
20	Sundaram C, Meena AK, Uppin MS, Govindaraj P, Vanniarajan A, Thangaraj K, Kaul S, Kekunnaya R and Murthy JM: Contribution of muscle biopsy and genetics to the diagnosis of chronic progressive external opthalmoplegia of mitochondrial origin. J Clin Neurosci. 18:535–538. 2011.PubMed/NCBI View Article : Google Scholar
21	Lehmann D, Kornhuber ME, Clajus C, Alston CL, Wienke A, Deschauer M, Taylor RW and Zierz S: Peripheral neuropathy in patients with CPEO associated with single and multiple mtDNA deletions. Neurol Genet. 2(e113)2016.PubMed/NCBI View Article : Google Scholar